Dronedarone in patients with congestive heart failure: insights from ATHENA

AIMS: Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hohnloser, Stefan H., Crijns, Harry J.G.M., van Eickels, Martin, Gaudin, Christophe, Page, Richard L., Torp-Pedersen, Christian, Connolly, Stuart J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2010
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903712/
https://ncbi.nlm.nih.gov/pubmed/20436046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehq113
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky